To assess the role of the transcription factor Sox9 in cartilage forma
tion we have compared the expression pattern of Sox9 and Col2 alpha 1
at various stages of mouse embryonic development, Expression of Col2 a
lpha 1 colocalized with expression of Sox9 in all chondroprogenitor ce
lls. In the sclerotomal compartment of somites the onset of Sox9 expre
ssion preceded that of Col2 alpha 1. A perfect correlation was also se
en between high levels of Sox9 expression and high levels of Col2 alph
a 1 expression in chondrocytic cells. However, no Sox9 expression was
detected in hypertrophic chondrocytes; only low levels of Col2 alpha 1
RNA were found in the upper hypertrophic zone, Coexpression of Sox9 a
nd Col2 alpha 1 was also seen in the notochord. At E11.5 Sox9 expressi
on in the brain and spinal neural tube was more widespread than that o
f Col2 alpha 1 although at E14.5 Sox9 and Col2 alpha 1 transcripts wer
e colocalized in discrete areas of the brain. Distinct differences bet
ween Sox9 and Col2 alpha 1 expression were observed in the otic vesicl
e at E11.5. At E8.5, expression of Sox9 but not of Col2 alpha 1 was se
en in the dorsal tips of the neural folds and after neural tube closur
e also in presumptive crest cells emigrating from the dorsal pole of t
he neural tube. No Col2 alpha 1 expression was detected in gonadal rid
ges in which high levels of Sox9 expression were detected. Together wi
th our previous results showing that the chondrocyte-specific enhancer
element of the Col2 alpha 1 gene is a direct target for Sox9, these r
esults suggest that Sox9 plays a major role in expression of Col2 alph
a 1. The correlation between high expression levels of Sox9 and high e
xpression levels of Col2 alpha 1 in chondrocytes suggests the hypothes
is that high levels of Sox9 are needed for full expression of the chon
drocyte phenotype; lower levels of Sox9 such as in neuronal tissues wh
ich are also associated with lower expression levels of Col2 alpha 1 w
ould be compatible with other cell specifications. (C) 1997 Wiley-Liss
, Inc.